---
layout: default
---

# Configurations

| UniProt Accession Number   | Reagent Type     | Target Name / Protein Biomarker   | Target Species   | Host Organism   | Isotype   | Clonality   | Vendor    |   Catalog Number | Conjugate   | RRID      | Availability   | Method           | Tissue Preservation               | Target Tissue   | Tissue State   | Detergent         | Antigen Retrieval Conditions   | Dye Inactivation Conditions                                            | Recommend   | Agree                                    | Disagree   | Contributor         | Notes   |
|:---------------------------|:-----------------|:----------------------------------|:-----------------|:----------------|:----------|:------------|:----------|-----------------:|:------------|:----------|:---------------|:-----------------|:----------------------------------|:----------------|:---------------|:------------------|:-------------------------------|:-----------------------------------------------------------------------|:------------|:-----------------------------------------|:-----------|:--------------------|:--------|
| P16070                     | Primary Antibody | CD44                              | Human            | Rat             | IgG2b     | IM7         | BioLegend |           103016 | AF488       | AB_493679 | Stock          | IBEX2D Automated | 1:4 Cytofix/Cytoperm Fixed Frozen | Jejunum         | NA             | 0.3% Triton-X-100 | NA                             | 0.5 mg/ml LiBH4 10 minutes continuous exchange with automated protocol | Yes         | [0000-0003-4379-8967](https://orcid.org/0000-0003-4379-8967) [[1](#publications)] | NA         | [0000-0003-4379-8967](https://orcid.org/0000-0003-4379-8967) |         |
| P16070                     | Primary Antibody | CD44                              | Human            | Rat             | IgG2b     | IM7         | BioLegend |           103016 | AF488       | AB_493679 | Stock          | IBEX2D Automated | 1:4 Cytofix/Cytoperm Fixed Frozen | Lymph Node      | NA             | 0.3% Triton-X-100 | NA                             | 0.5 mg/ml LiBH4 10 minutes continuous exchange with automated protocol | Yes         | [0000-0003-4379-8967](https://orcid.org/0000-0003-4379-8967) [[1](#publications)] | NA         | [0000-0003-4379-8967](https://orcid.org/0000-0003-4379-8967) |         |
| P16070                     | Primary Antibody | CD44                              | Human            | Rat             | IgG2b     | IM7         | BioLegend |           103016 | AF488       | AB_493679 | Stock          | IBEX2D Automated | 1:4 Cytofix/Cytoperm Fixed Frozen | Skin            | NA             | 0.3% Triton-X-100 | NA                             | 0.5 mg/ml LiBH4 10 minutes continuous exchange with automated protocol | Yes         | [0000-0003-4379-8967](https://orcid.org/0000-0003-4379-8967) [[1](#publications)] | NA         | [0000-0003-4379-8967](https://orcid.org/0000-0003-4379-8967) |         |

# Publications

<a name="publications"></a>
1. A. J. Radtke et al., "IBEX: an iterative immunolabeling and chemical bleaching
 method for high-content imaging of diverse tissues", *Nat. Protoc.*, 17(2):378-401, 2022, [doi: 10.1038/s41596-021-00644-9](https://doi.org/10.1038/s41596-021-00644-9).

    A. J. Radtke et al., "Accompanying dataset for: IBEX: An iterative immunolabeling and chemical bleaching method for high-content imaging of diverse tissues", [doi: 10.5281/zenodo.5244550](https://doi.org/10.5281/zenodo.5244551).


# Additional Notes

<a name="notes"></a>

